MalVax Alliance logo with a geometric star-shaped emblem and the name stacked in bold text.

The Malaria Vaccine (MalVax) Alliance

Accelerating the development of better vaccines for a malaria free future.

INTRODUCING MALVAX

The Malaria Vaccine (MalVax) Alliance is a new global, independent collaboration accelerating the development of malaria vaccines.

The MalVax Alliance unites the malaria vaccine R&D community to drive evidence and innovation from lab to policy faster, so better vaccines reach the people who need them sooner. It coordinates action around shared priorities by:

Strengthening innovation and clinical investigation through shared frameworks

Improving the quality and comparability of research evidence

Accelerating the translation of that evidence into regulatory and policy decisions

Objectives

Together, we are working to:

This is some text inside of a div block.

Share Science

Strengthen scientific exchange and shared knowledge across the community.

‍

This is some text inside of a div block.

Break Bottlenecks

Coordinate expertise to address common research and development challenges.

This is some text inside of a div block.

Align Efforts

Improve comparability and support evidence generation across the ecosystem.

MalVax 2027: The First Global Malaria Vaccine Alliance R&D Conference

Kuala Lumpur, Malaysia
31 January - 3 February 2027
In-Person
Organised by a Scientific Conference Committee.
Learn more about the Conference

Latest News

Stay up to date with the latest developments from MalVax Alliance.

Working Groups

MalVax Working Groups Co-Chairs Announced:

We are pleased to announce the Working Group Co-Chairs have now been confirmed and are actively setting up and organising their groups to address the most pressing barriers to next-generation malaria vaccine R&D. Planning is underway to create opportunities for community consultation beyond Working Group members to ensure you all have a chance to feed into this important work. Interactive sessions with the Working Groups will also be included on the MalVax 2027 conference programme.

You can find out more about our Working Groups here

Conference

Register and book your travel— MalVax 2027

The conference will take place in Kuala Lumpur, 31 January to 3 February 2027 at the Shangri-La Hotel. A discounted room block has been arranged at the venue for conference participants. Click here for more information and to reserve your room.

MalVax Alliance

Building the MalVax Alliance

The Executive Committee and Support Unit continue to establish MalVax, including Working Groups, governance structures, and community engagement activities.

Read More

Get involved

Stay Informed about MalVax

The success of the MalVax Alliance depends on the strength of its community. Whether you are a researcher, clinician, laboratory scientist, vaccine developer, modeller, policymaker, regulator, funder, or implementation partner, we invite you to be part of this collaborative effort to accelerate the development of next-generation malaria vaccines.

‍

If you have not done so yet, please complete our engagement form using the link below to receive updates about the MalVax Alliance and the MalVax 2027 conference.

Contact Us

For questions about MalVax, visit our FAQs.

For any additional questions, please contact the Support Unit at Bridges to Development.

‍

Social Media

We encourage interested partners to follow us on social media and use the following hashtags:

#MalVaxAlliance #MalVax2027

FUNDER

Coefficient Giving

The establishment of the MalVax Alliance and the initiation of the inaugural conference has been made possible thanks to support from Coefficient Giving.